Buy or sell TeselaGen stock pre IPO via an EquityZen fund
TeselaGen is accelerating the design and fabrication of DNA with synthetic biology software.
About TeselaGen Stock
TeselaGen is building a rapid prototyping system for fast bio-based construction of sustainably sourced chemicals, therapeutic medicines, and novel vaccines. Their customers are biopharmaceutical and bioindustrial companies like Amgen and Genomatica. Their bioCAD/CAM system is based on technology exclusively licensed from Lawrence Berkeley National Lab and is being beta tested by hundreds of users.
Founder and Chief Scientific Officer
Founder & CEO
Founder & CTO
TeselaGen Is Building A Platform For Rapid Prototyping in Synthetic Biology
TechCrunch - Mar, 10 2014